LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.29 | 84.90 | 841 | 766 | 1.0967 | 1.0590 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 17.99 | 84.90 | 184 | 898 | 0.2047 | 0.2551 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 17.99 | 84.90 | 829 | 898 | 0.9222 | 0.9530 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 17.99 | 84.90 | 258 | 898 | 0.2870 | 0.3861 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 17.99 | 84.90 | 847 | 898 | 0.9422 | 0.9653 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 19.69 | 84.90 | 409 | 1239 | 0.3300 | 0.5016 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 19.69 | 84.90 | 828 | 1239 | 0.6681 | 0.8019 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 19.69 | 84.90 | 358 | 1239 | 0.2888 | 0.4507 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 19.69 | 84.90 | 837 | 1239 | 0.6753 | 0.8070 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 21.40 | 84.90 | 625 | 1454 | 0.4297 | 0.6275 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 21.40 | 84.90 | 836 | 1454 | 0.5747 | 0.7472 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 21.40 | 84.90 | 529 | 1454 | 0.3637 | 0.5626 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 21.40 | 84.90 | 861 | 1454 | 0.5919 | 0.7598 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 23.10 | 84.90 | 652 | 1616 | 0.4034 | 0.6154 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 23.10 | 84.90 | 840 | 1616 | 0.5197 | 0.7146 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 23.10 | 84.90 | 523 | 1616 | 0.3236 | 0.5338 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 23.10 | 84.90 | 864 | 1616 | 0.5346 | 0.7260 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 24.81 | 84.90 | 663 | 1769 | 0.3747 | 0.5986 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 24.81 | 84.90 | 840 | 1769 | 0.4747 | 0.6873 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 24.81 | 84.90 | 503 | 1769 | 0.2843 | 0.5009 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 24.81 | 84.90 | 846 | 1769 | 0.4781 | 0.6900 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 26.51 | 84.90 | 669 | 1923 | 0.3479 | 0.5818 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 26.51 | 84.90 | 852 | 1923 | 0.4430 | 0.6691 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 26.51 | 84.90 | 513 | 1923 | 0.2668 | 0.4912 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 26.51 | 84.90 | 861 | 1923 | 0.4477 | 0.6730 | MN20160318_Q02 | N03 |